PUBLISHER: The Business Research Company | PRODUCT CODE: 1945534
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945534
Medical device contract manufacturing involves a process in which a Medtech company, which owns the intellectual property, outsources the manufacturing of medical devices to another specialized manufacturing firm. This outsourcing arrangement is often chosen for benefits such as cost optimization, device upgrades, regulatory guidance, or expansion purposes.
The main types of medical devices in contract manufacturing include in vitro diagnostic (IVD) devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, endoscopy devices, ophthalmology devices, orthopedic devices, dental devices, and other devices. In vitro diagnostic (IVD) devices are medical devices used alone or in combination with other diagnostic products for in vitro use, including apparatus, equipment, or systems. The services provided by medical device contract manufacturing include device development and manufacturing services, quality management services, and assembly services. The applications of contract manufacturing services span various medical fields, including laparoscopy, pulmonary, urology, gynecology, and other applications.
Tariffs are impacting the medical device contract manufacturing market by increasing costs of imported raw materials, electronic components, precision parts, and specialized manufacturing equipment used across diagnostics, cardiovascular, and drug delivery devices. North America and Europe are most affected due to cross-border sourcing of components, while Asia-Pacific faces cost pressure on export-oriented manufacturing hubs. These tariffs are increasing production costs and affecting pricing strategies for OEMs. However, they are also encouraging regional manufacturing diversification, local sourcing initiatives, and long-term investments in domestic contract manufacturing capabilities.
The medical device contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides medical device contract manufacturing market statistics, including medical device contract manufacturing industry global market size, regional shares, competitors with a medical device contract manufacturing market share, detailed medical device contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract manufacturing industry. This medical device contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical device contract manufacturing market size has grown rapidly in recent years. It will grow from $114.66 billion in 2025 to $131.36 billion in 2026 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to rising medical device innovation cycles, increasing regulatory complexity in medtech manufacturing, growing cost pressures on OEMs, expansion of global medtech startups, demand for specialized manufacturing expertise.
The medical device contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $228.23 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing adoption of advanced manufacturing technologies, rising demand for rapid device commercialization, expansion of personalized and minimally invasive devices, growing focus on supply chain resilience, increasing partnerships between OEMs and CMOs. Major trends in the forecast period include increasing outsourcing of complex device manufacturing, rising demand for end-to-end contract manufacturing services, growing focus on regulatory-compliant production capabilities, expansion of scalable manufacturing infrastructure, enhanced emphasis on quality and risk management.
The increasing prevalence of chronic disorders is anticipated to drive the expansion of the medical device contract manufacturing market in the coming years. Chronic disorders are long-term health conditions, including cardiovascular diseases, diabetes, and respiratory illnesses, that persist over extended periods and typically require ongoing medical care, monitoring, and intervention. The growing burden of these conditions is largely attributed to aging populations and lifestyle-related factors, as longer life expectancy combined with sedentary habits, unhealthy diets, and reduced physical activity contributes to higher incidence rates of chronic diseases. This rising prevalence fuels demand for a wide range of specialized medical devices, such as monitoring systems, implantable products, and diagnostic equipment, which are essential for effective long-term disease management. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a United States-based organization, 76.4 percent of U.S. adults, representing around 194 million people, reported having at least one chronic condition, while 51.4 percent, or approximately 130 million individuals, reported living with two or more chronic conditions. Consequently, the growing prevalence of chronic disorders is supporting the growth of the medical device contract manufacturing market.
Leading companies operating in the medical device contract manufacturing sector are increasingly emphasizing innovative initiatives such as integrated new product introduction (NPI) platforms to accelerate device development and enable smooth transitions to large-scale production. Integrated NPI platforms are comprehensive, end-to-end systems that bring together design, prototyping, testing, and manufacturing readiness within a unified workflow, allowing medical device companies to shorten development timelines, enhance quality assurance, reduce production risks, and speed up the shift from concept to commercialization. For example, in March 2025, Flex Ltd., a United States-based manufacturing company, announced the launch of its new NPI Center near Boston, a prominent global hub for medical technology innovation. The facility is designed to strengthen end-to-end product realization and includes an 8,000 square foot development laboratory capable of supporting concurrent prototype and preclinical builds, along with a 2,000 square foot validation and quality testing area, and is planned to achieve ISO 13485 certification by the second quarter of 2025. Supporting applications across surgical robotics, medical devices, imaging systems, and laboratory diagnostics, the center enables original equipment manufacturers to lower development risks, reduce time-to-market, and benefit from an integrated manufacturing ecosystem.
In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Binding Site Group for around $2.8 billion. This acquisition enhances Thermo Fisher's specialty diagnostics portfolio by incorporating innovative diagnostics and monitoring solutions for multiple myeloma. This expansion facilitates earlier diagnosis and enables more informed treatment decisions, ultimately improving patient outcomes. Thermo Fisher is committed to advancing this field further for the benefit of patients. Binding Site Group is a UK-based company that specializes in medical device contract manufacturing.
Major companies operating in the medical device contract manufacturing market are Phillips-Medisize Corporation, Integer Holdings Corporation, Flex Ltd, Sanmina Corporation, Plexus Corporation, Benchmark Electronics Inc, Celestica International LP, Jabil Inc, Kimball Electronics Inc, Nortech Systems Inc, Gerresheimer AG, Catalent Inc, Nemera Development S.A., Consort Medical plc, Invetech, SteriPack Group Ltd, Forefront Medical Technologies Pte Ltd, Nipro Corporation, TE Connectivity Ltd, West Pharmaceutical Services Inc
North America will be the largest region in the medical device contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical device contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The medical device contract manufacturing market includes revenues earned by entities by quality management system, ISO certified clean rooms, sterilization validation and recurring services, package design and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Device Contract Manufacturing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical device contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical device contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device contract manufacturing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.